HomeStock ScreenerFDCQuarterly Results

FDC Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹103 Cr
QMar 2026
Quarterly Results

In Mar 2026, FDC (FDC) reported revenue ₹635 Cr and net profit ₹103 Cr — revenue +25.0% YoY. Also explore FDC share price charts to track price trends across different timeframes.

FDC Quarterly Results — Revenue, Profit & EPS Highlights

FDC latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit FDC stock price BSE.

  • Revenue of ₹635 Cr in Mar 2026 (+28.5% vs Sept 2025, +25.0% vs Mar 2025)
  • Net Profit of ₹103 Cr in Mar 2026 (+267.9% vs Sept 2025, +164.1% vs Mar 2025)
  • EBITDA of ₹156 Cr in Mar 2026 (+188.9% vs Sept 2025)
  • Operating Margin of 18.0% in Mar 2026 (+11.0pp vs Sept 2025)
  • Earnings Per Share of ₹6.35 in Mar 2026 (+262.9% vs Sept 2025)

FDC Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FDC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 635 494 508 684 486 28.5% 25.0%
Net Profit (₹ Cr) 103 28 39 121 28 - -
EBITDA (₹ Cr) 156 54 70 176 52 - -
EPS (₹) 6.35 1.75 2.38 7.45 1.74 - -
Operating Margin (%) 18.0% 7.0% 11.0% 22.0% 7.0% - -

FDC Share Price Trend — 1-Year Movement Across Quarterly Results

FDC 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Browse FDC balance sheet details for revenue, profit, balance sheet and cash flow data.

Profitability Ratios

Profit Margin 16.2%
EBITDA Margin 24.6%
Operating Margin 18.0%
ROE (Annual) 16.6%

Balance Sheet Highlights

Total Assets ₹2,919 Cr
Total Equity ₹2,485 Cr
Current Assets ₹1,133 Cr
Current Liabilities ₹70 Cr

Cash Flow Analysis

Operating Cash Flow ₹318 Cr
Investing Cash Flow ₹-199 Cr
Financing Cash Flow ₹-92 Cr
Net Cash Flow ₹26 Cr

Current Market Data

Current Price ₹412.95
Exchange NSE
Last Updated Jul 24, 2026

FDC vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

FDC latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026
₹469,405.89 Cr 1941.1 15,018 2,710 +1.0% +11.8% 18.0% 171.8
Divis Laboratories
Mar 2026
₹194,269.91 Cr 7248.5 2,986 751 +4.4% +11.8% 25.2% 256.0
Torrent Pharmaceuti…
Mar 2026
₹191,454.40 Cr 4961.5 4,111 364 +27.7% +42.2% 8.9% 431.1
Zydus Life Science
Mar 2026
₹115,616.29 Cr 1108.7 7,569 1,341 +23.1% +18.8% 17.7% 87.6
Cipla
Mar 2026
₹114,318.19 Cr 1410.6 6,612 543 -14.3% -4.0% 8.2% 205.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores